Introduction
In cystic fibrosis (CF), the defective structure and function of the cystic fibrosis transmembrane conductance regulator (CFTR) in airway epithelial cells and submucosal glands 1 results in chronic bronchopulmonary infection with mucoid strains of Pseudomonas aeruginosa 2 via pathogenic mechanisms that are still being elucidated. This chronic infection is associated with an intense inflammatory response which leads to airway obstruction, tissue destruction and impaired clearance of infected secretions, a pathologic process that accounts for most of the morbidity and almost all of the mortality in CF. 2 The inflammation of the CF lung associated with chronic bronchopulmonary infection with mucoid strains of P. aeruginosa is characterized by a massive influx of neutrophils (PMN) into the airways. These cells are the source of oxidants and proteolytic enzymes, especially neutrophil elastase (NE), which cause tissue injury and other important adverse effects. Additionally, residual DNA and actin greatly increase viscosity of airway secretions. 2 Markedly elevated levels of pro-inflammatory cytokines, including TNF-␣, IL-1␤, IL-6 and IL-8, have also been measured in airway secretions of CF patients. 3 This chronic inflammatory response in the lung is associated with an exaggerated humoral response to Pseudomonas antigens, leading to the formation of immune complexes which may contribute to the progression of pulmonary disease. 4 The elucidation of the gene defect in CF as a mutation in the structural gene for CFTR has given promise to the prospect for gene replacement therapy for this disease. There are several different approaches for the delivery of genes to the respiratory tract. Recombinant adenoviruses have been used to transfer the gene encoding CFTR in vitro and in vivo, and clinical trials are in progress at several major CF centers in the USA. [5] [6] [7] [8] [9] [10] Several potential barriers to successful adenovirus-mediated gene transfer to the airways have been recognized which include the need for repeated delivery to maintain transgene expression, 11 the host inflammatory response to the vector, and specific immune responses to adenovirus vectors. [12] [13] [14] In vivo models used so far to conduct published studies of adenovirus-mediated gene transfer to the lungs have employed animals with uninfected, uninflamed lungs at the time of vector administration. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Given the prominence of the chronic infection and inflammation in the airways of CF patients, we examined the influence of chronic bronchopulmonary inflammation induced by P. aeruginosa on the delivery of transgenes to airway epithelium. In the current studies, we tested the hypo-thesis that lung inflammation in mice induced by P. aeruginosa will be associated with a quantitative reduction in short-term, adenovirus-mediated reporter gene expression in airway epithelial cells.
Results
Characteristics of chronic pulmonary infection with Pseudomonas aeruginosa in mice: weight loss in mice after inoculation with Pseudomonas-laden agarose beads At the onset of the experiment, mice weighed 19.7 ± 0.2 g. Untreated mice gained weight over the course of 3 days (+5.4 ± 1.1%). Mice that received P. aeruginosa-laden agarose beads lost significantly (P Ͻ 0.015) more weight than mice that received sterile agarose beads (−9.9 ± 2.2% and −1.56 ± 1.8%, respectively). This increased weight loss served as early confirmation of successfully established Pseudomonas infection in the mice.
Absolute cell numbers in bronchoalveolar lavage fluid from mice As shown in Figure 1 , the average absolute neutrophil (PMN) count in bronchoalveolar lavage (BAL) fluid from mice receiving Pseudomonas-laden agarose beads and Ad2/␤Gal-2 (1.8 ± 0.8 × 10 5 cells/ml; n = 8) was significantly higher (P Ͻ 0.0006) than that from control mice which received sterile agarose beads and Ad2/␤Gal-2 (0.6 ± 0.4 × 10 5 cells/ml; n = 8). The absolute number of PMN in BAL fluid from mice which had received no beads before inoculation with Ad2/␤Gal-2 (0.6 ± 0.1 × 10 5 cells/ml; n = 9) was similar to that of mice which received sterile agarose beads.
Areal inflammation in lung histopathology sections from mice inoculated with agarose beads and Ad2/␤Gal-2 Representative photomicrographs of lung sections are shown in Figure 2 . Sterile agarose beads are associated with minimal inflammation (Figure 2A ), while P. aeruginosa-laden agarose beads are associated with an intense inflammatory response ( Figure 2B ). A combined analysis of five sections per lung, was performed to determine the areal inflammation of mice receiving agarose beads and adenovirus. As shown in Figure 3 , areal inflammation was greatest in mice that had been inoculated with P. aeruginosa-laden agarose beads and Ad2/␤Gal-2 (24.9 ± 2.7%), and was significantly different (P Ͻ 0.00015) from controls that had received sterile agarose beads and Ad2/␤Gal-2 (5.3 ± 1.1%). The areal lung inflammation in mice which had received Ad2/␤Gal-2 alone (8.5 ± 1.8%) was not significantly different from that of mice which received sterile agarose beads and adenovirus. These results, together with BAL neutrophil counts, demonstrate the presence of an increased inflammatory response induced by Pseudomonas-laden agarose beads compared with controls.
Effect of chronic bronchopulmonary infection on adenoviral gene transfer
Three days after intranasal inoculation with Ad2/␤Gal-2 and 13 days after transtracheal inoculation with agarose beads, lungs underwent cytochemical staining for ␤-galactosidase activity, as described above. A representative photomicrograph of a lung section from a mouse inoculated with Ad2/␤Gal-2 alone is shown in Figure 2C . Although expression of the transgene was also detected in the alveolar pneumocytes and macrophages, only airway epithelial cells expressing ␤-galactosidase were assessed in our evaluation of gene transfer. As shown in Figure 4 , mice that had received sterile agarose beads followed by Ad2/␤Gal-2 had 9.4 ± 1.4% airway epithelial cells transduced by the adenovirus vector. In contrast, ␤-galactosidase expression was significantly decreased (P Ͻ 0.015) in mice that had received P. aeruginosa-laden agarose beads and Ad2/␤Gal-2 (4.1 ± 0.9%). Reporter gene expression in mice that received no beads before receiving the adenovirus vector was similar to that for the sterile agarose bead group (9.6 ± 0.9%), indicating that the agarose beads alone had no significant effect on gene transfer. Figure 5 shows the distribution of data and shows a clear separation of the data from P. aeruginosainoculated mice and their controls, with very little overlap for gene expression and none for areal inflammation.
Discussion
Recombinant adenovirus vectors are being studied and refined for gene therapy in the lungs of CF patients. Because chronic airway infection and inflammation is a prominent feature of CF lung disease, it is important to understand the influence of this chronic inflammatory milieu on the efficacy of adenovirus-mediated gene transfer to the airway epithelium. We used a murine model of chronic Pseudomonas-induced lung inflammation to test the hypothesis that chronic pulmonary inflammation would lead to reduced efficacy of adenovirus-mediated transgene expression in airway epithelium. We confirmed our hypothesis in this model, showing a significant reduction in short-term transgene expression in airway epithelial cells.
The agarose bead model of chronic bronchopulmonary infection has been used by several investigators to study the effects of Pseudomonas infection in several animal species, [21] [22] [23] [24] [25] [26] [27] and to study the efficacy of treatments to control chronic inflammation. [28] [29] [30] [31] [32] [33] [34] The histopathologic features of rats 35 and mice 36 inoculated with P. aeruginosaladen agarose beads closely mimics that of CF patients, which includes endobronchitis, bronchopneumonia, bronchiectasis, mucus plugging and alveolar exudates with acute and chronic inflammatory cells. The inoculation of sterile agarose beads is associated with minimal inflammation, 36 however, as confirmed in the current study.
An important question regarding the agarose bead model is whether or not the introduction of the agarose beads themselves may decrease the efficacy of adenovirus-mediated gene transfer due to possible obstruction. Therefore, a control group consisting of mice receiving sterile agarose beads was included. The results of gene transfer in mice receiving sterile agarose beads followed by Ad2/␤Gal-2, and mice receiving Ad2/␤Gal-2 alone were no different. This indicates that the presence of the beads alone did not lead to a decrease in the efficacy of gene transfer. Therefore, the Pseudomonas-induced inflammation was responsible for the decrease in adenovirus-mediated gene transfer.
The mechanism by which inflammation caused by P. aeruginosa reduces adenovirus-mediated gene transfer remains to be determined but may involve several factors. The aqueous portion of CF sputum (CF sol) has been found to decrease the efficacy of Ad2/␤Gal-2-mediated gene transfer in vitro, and this effect has been at least partially attributed to neutrophil elastase activity. 37 Therefore, viral surface proteins or their cellular surface receptor(s) may undergo proteolysis by neutrophil elastase and/or damage by oxidants in secretions of infected airways. These proteins include the fiber protein of the viral capsid and its receptors on host cells, 38 including the recently described coxsackievirus and adenovirus receptor (CAR) 39 and the alpha-2 domain of major histocompatibility (MHC) class I, 40 in addition to the penton base complex of viral capsid and the ␣ v ␤3 and ␣ v ␤5 integrins on the host cell membrane. 41 Of further interest is the observation that P. aeruginosa has been found to upregulate the expression of the mucin gene MUC 2.
42 This may be relevant because related molecules such as MUC1 and other sialylated glycoconjugates have been shown to decrease adenovirus-mediated gene transfer, possibly by interfering with viral attachment or internalization. 43 In the future, better understanding of the mechanisms by which this inflammation interferes with adenovirusmediated gene transfer may lead to more specific approaches to enhancing gene transfer in CF patients with inflamed airways.
Our findings suggest that for optimal gene therapy using adenovirus vectors in the CF lung there should be as little inflammation as possible present in the lung at the time of vector administration. This might be achieved by administration of this therapy at the youngest possible age, when inflammation should be at its earliest stages. Alternatively, effective anti-inflammatory therapy might be used to prepare patients before vector administration. If proteolytic activity in CF airway secretions is confirmed as an important mechanism of interference with adenovirus-mediated gene transfer, then anti-protease therapy, such as ␣1-antitrypsin, could be used to neutralize the abundant NE in the airways before adenoviral administration.
In addition to the pre-existing inflammation due to chronic bronchopulmonary infection with P. aeruginosa in CF patients, adenovirus administration may increase the amount of inflammation already present, either in an additive or synergistic fashion. Adenovirus has been known to induce specific host inflammatory responses in healthy people and animals, even after a single administration, 12 although adenovirus vectors with reduced immunogenicity and inflammatory potential are being developed.
In conclusion, the results of this study indicate that bronchopulmonary inflammation due to P. aeruginosa decreases the efficacy of adenovirus-mediated gene transfer in mice. The mechanism by which this occurs has yet to be determined. It is likely that in order to optimize adenovirus-mediated gene therapy for correcting CF, adenovirus vectors should be administered either early in the course of the disease or in conjunction with effective anti-inflammatory therapy.
Materials and methods

Reagents
Reagents were obtained from Fisher Scientific (Pittsburgh, PA, USA) or Sigma (St Louis, MO, USA) unless otherwise stated.
Experimental model of chronic P. aeruginosa infection Male C57BL/6 mice (6 to 8 weeks old) were obtained from Charles River Laboratories, Wilmington, MA, USA. These specific pathogen-free mice were maintained in microisolator units and fed autoclaved rodent chow and water ad libitum. The agarose bead method, initially described for rats 35 and later adapted for use in mice, 36 was used to create chronic pulmonary infection with P. aeruginosa in mice in the current studies, with minor modifications. P. aeruginosa strain M57-15 is a mucoid strain isolated from a cystic fibrosis patient at Rainbow Babies and Childrens Hospital. It was maintained in frozen stocks in 10% glycerol and subsequently cultured on tryptic soy agar (TSA) before inoculation in tryptic soy broth (TSB) for preparation of agarose beads. Agarose (low EEO) was mixed with TSB containing mucoid P. aeruginosa strain M57-15 at late log phase. The agarosebroth mixture was added to mineral oil that was equilibrated at 50-55°C, then rapidly stirred for 6 min at 24°C, and cooled over 10 min. The agarose beads were washed once with 0.5% deoxycholic acid, sodium salt (SDC) in phosphate buffered saline, pH 7.4 (PBS), once with 0.25% SDC in PBS, and four times with PBS. Quantitative bacteriology was performed on an aliquot of homogenized 349 bead slurry to determine the number of c.f.u. per ml of bead slurry. Sterile control beads were prepared identically except bacteria were absent. Sterility was confirmed by agar plating. The average diameter of the beads was 100-120 microns. Mice were anesthetized with 2.5% avertin (2,2,2-tribromoethanol and tert-amyl alcohol in 0.9% NaCl) administered i.p. (0.015 ml/g body weight), placed in dorsal recumbency, and the ventral cervical area was surgically prepared. A transverse skin incision was made, and the trachea was visualized by blunt dissection. Transtracheal insertion of soft catheter via a 22 G 11 inch stylet was used to instill 50 l of a 1:10 dilution of the bead slurry in PBS directed to the right mainstem bronchus. A unilateral inoculation was chosen because bilateral inoculation of mice leads to higher mortality. 36 Mice were inoculated with sterile agarose beads or P. aeruginosa-laden agarose beads (6 × 10 4 c.f.u. per mouse). Sterile agarose beads were employed as a control to account for the possibility that obstruction due to the beads themselves might reduce gene transfer. Thus, the effects of inflammation independent of the beads per se could be assessed. A separate control group consisted of mice not subjected to any of the above procedures. Mice were weighed before the administration of agarose beads, 3 days post-operatively and then daily until the mice regained their weight. The animal research protocol was reviewed and approved by the Case Western Reserve University Institutional Animal Care and Use Committee.
Administration of adenovirus to mice
A replication-deficient adenovirus type 2 (Ad2/␤Gal-2) was obtained from Drs Johanne Kaplan and Alan Smith, Genzyme, Framingham, MA, USA. In this vector, 18 the entire E1 region was replaced with an expression cassette containing lacZ under the control of the CMV promoter, and the E4 region was modified to contain only ORF6. The titer was 2.26 × 10 10 IU/ml with 83.6 particles per IU. Ten days after inoculation with agarose beads, mice were anesthetized with ether and allowed to inhale 50 l of saline that contained the Ad2/␤Gal-2 vector (1.1 × 10 9 IU per mouse) intranasally.
Collection and processing of cells and tissues from mice Three days after mice were inoculated with Ad2/␤Gal-2, the mice were killed by carbon dioxide anoxia, followed by exsanguination. The pulmonary circulation was perfused with 1 ml PBS via the right ventricle. Bronchoalveolar lavage (BAL) was performed by cannulating the trachea in situ with a 22 G 1. inch bead-tipped feeding needle. The lungs were lavaged with 1 ml sterile PBS, collecting the fluid by gentle aspiration with recovery of 0.7 to 1.0 ml of the lavage. The resulting BAL fluid was centrifuged at 150 g for 10 min. The pellet was resuspended in 1 ml of PBS, a cell count was performed and a differential cell count was determined from cytospin preparations using standard techniques.
Histochemical staining of lungs for ␤-galactosidase expression in airway epithelial cells Following BAL, the trachea and lungs were stained in situ with a solution of 5-bromo-4-chloro-3-indolyl-␤-galactopyranoside (X-gal) prepared as previously described. 44 The lungs were washed with 1 ml of 0.1 m PIPES buffer and then inflated with 1 ml of 2% paraformaldehyde in 0.1 m PIPES buffer for 10 min. The lungs were washed twice with 0.1 m PIPES buffer. The lungs were then inflated with 1 ml of X-gal solution and allowed to incubate in 5 ml of X-gal solution overnight at room temperature. The right lung was evaluated using a systematic approach to quantitative morphometry described by Bolender et al. 45 Briefly, following X-gal staining the lungs were inflation-fixed in 1% agarose, 1% paraformaldehyde in PBS. The lung was cut once mid-sagitally, and embedded in paraffin. Tissue sections were cut throughout the entire tissue block such that 10 5-m sections were taken at regular intervals that encompassed the full craniocaudal range of sections. Sections 1-10 were counterstained with nuclear fast red (NFR) to evaluate ␤-galactosidase expression, and sections immediately adjacent to oddnumbered sections, designated 1a, 3a, 5a, 7a and 9a, were stained with hematoxylin and eosin (H&E) to evaluate inflammation. Lung sections were stained with NFR and H&E using standard techniques.
A test grid was used to determine the percentage of airway epithelial cells expressing ␤-galactosidase in all sections 1-10, from each right lung. The lung sections were evaluated at ×400 magnification at every 1 mm increment in both the x and y direction using an automatic point counter (Prior Scientific, Rockland, MA, USA) and video camera mounted on a light microscope. A test grid square consisted of a 19 × 19 cm box superimposed on the video screen, upon which the image of the microscope slide was displayed. The actual size of the test grid square was 271 × 271 microns. The percentage of airway epithelial cells expressing ␤-galactosidase (blue cells) was determined by dividing the number of blue airway epithelial cells falling under the test grid square by the total number of airway epithelial cells falling under the test grid square.
Quantification of areal inflammation in lungs
A point counting test grid was used to quantify the inflammation present in five sections per lung. Every millimeter (in both the x and y direction) of the histopathology slides was evaluated at ×40 magnification using a cross-hair eyepiece and an automatic point counter. The percentage of areal lung inflammation was determined by dividing the number of points falling on inflammatory foci by the total number of points falling on lung. Inflammatory foci were defined as areas of leukocyte infiltration, and included peribronchial/perivascular inflammation, endobronchial inflammation and parenchymal inflammation.
Statistical analysis
Data are expressed as the mean ± standard error of the mean (s.e.m.). Percentage weight change was evaluated using the Mann-Whitney Rank Sum test. Quantitative data for absolute cell number in bronchoalveolar lavage fluid, areal lung inflammation and percentage airway epithelial cells expressing ␤-galactosidase for right lungs of mice for all three experimental groups were evaluated by ANOVA. Subsequent comparisons between groups were made using Mann-Whitney Rank Sum test (SigmaStat Version 1.0; Jandel, San Rafael, CA, USA).
